• 1
    Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 67587.
  • 2
    Tunstall-Pedoe H, Vanuzzo D, Hobbs M et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. [see comment]. Lancet 2000; 355: 688700.
  • 3
    Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. [see comment]. Lancet 1999; 353: 154757.
  • 4
    Björck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30: 104656.
  • 5
    Vartiainen E, Laatikainen T, Peltonen M et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 50418.
  • 6
    Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. [see comment]. Lancet 2004; 364: 93752.
  • 7
    Whitlock G, Lewington S, Sherliker P et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 108396.
  • 8
    Strand BH, Groholt EK, Steingrimsdottir OA, Blakely T, Graff-Iversen S, Naess O. Educational inequalities in mortality over four decades in Norway: prospective study of middle aged men and women followed for cause specific mortality, 1960–2000. BMJ 2010; 340: c654.
  • 9
    Kivimaki M, Shipley MJ, Ferrie JE et al. Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study. Lancet 2008; 372: 164854.
  • 10
    O’Flaherty M, Bishop J, Redpath A et al. Coronary heart disease mortality among young adults in Scotland in relation to social inequalities: time trend study. BMJ 2009; 339: b2613.
  • 11
    Rosengren A, Subramanian SV, Islam S et al. Education and risk for acute myocardial infarction in 52 high, middle and low-income countries: INTERHEART case–control study. Heart 2009; 95: 201422.
  • 12
    Kuklina EV, Yoon PW, Keenan NL. Trends in high levels of low-density lipoprotein cholesterol in the United States, 1999-2006. JAMA 2009; 302: 210410.
  • 13
    Vartiainen E, Laatikainen T, Peltonen M et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 50418.
  • 14
    Berg CM, Lissner L, Aires N et al. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil 2005; 12: 11525.
  • 15
    Rosengren A, Eriksson H, Hansson PO et al. Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50. J Intern Med 2009; 266: 26876.
  • 16
    Molarius A, Parsons RW, Dobson AJ et al. Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health 2001; 91: 20612.
  • 17
    Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Waist and hip circumferences, and waist–hip ratio in 19 populations of the WHO MONICA Project. Int J Obes Relat Metab Disord 1999; 23: 11625.
  • 18
    Silventoinen K, Sans S, Tolonen H et al. Trends in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord 2004; 28: 7108.
  • 19
    Gregg EW, Cheng YJ, Cadwell BL et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005; 293: 186874.
  • 20
    Lundblad D, Holmgren L, Jansson JH, Naslund U, Eliasson M. Gender differences in trends of acute myocardial infarction events: the Northern Sweden MONICA study 1985–2004. BMC Cardiovasc Disord 2008; 8: 17.
  • 21
    Rautio A, Eliasson M, Stegmayr B. Favorable trends in the incidence and outcome in stroke in nondiabetic and diabetic subjects. Findings from the Northern Sweden MONICA Stroke Registry in 1985 to 2003. Stroke 2008; 39: 313744.
  • 22
    Stegmayr B, Lundberg V, Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003; 61: 917.
  • 23
    Lilja M, Eliasson M, Stegmayr B, Olsson T, Soderberg S. Trends in obesity and its distribution: data from the Northern Sweden MONICA Survey, 1986–2004. Obesity (Silver Spring) 2008; 16: 11208.
  • 24
    Eliasson M, Janlert U, Jansson JH, Stegmayr B. Time trends in population cholesterol levels 1986–2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J Intern Med 2006; 260: 5519.
  • 25
    Eliasson M, Lindahl B, Lundberg V, Stegmayr B. No increase in the prevalence of known diabetes between 1986 and 1999 in subjects 25–64 years of age in northern Sweden. Diabet Med 2002; 19: 87480.
  • 26
    Stegmayr B, Eliasson M, Rodu B. The decline of smoking in northern Sweden. Scand J Public Health 2005; 33: 3214.
  • 27
    Krachler B, Eliasson MC, Johansson I, Hallmans G, Lindahl B. Trends in food intakes in Swedish adults 1986–1999: findings from the Northern Sweden MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Study. Public Health Nutr 2005; 8: 62835.
  • 28
    Norberg M, Wall S, Boman K, Weinehall L. The Vasterbotten Intervention Programme: background, design and implications. Glob Health Action 2010; 3: 4643 DOI: 10.3402/gha.v3i0.4643.
  • 29
    Nyholm M, Gullberg B, Merlo J, Lundqvist-Persson C, Rastam L, Lindblad U. The validity of obesity based on self-reported weight and height: implications for population studies. Obesity (Silver Spring) 2007; 15: 197208.
  • 30
    Eliasson M, Asplund K, Evrin PE, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study. Atherosclerosis 1995; 113: 4153.
  • 31
    Peltonen M, Huhtasaari F, Stegmayr B, Lundberg V, Asplund K. Secular trends in social patterning of cardiovascular risk factor levels in Sweden. The Northern Sweden MONICA Study 1986–1994. Multinational Monitoring of Trends and Determinants in Cardiovascular Disease. J Intern Med 1998; 244: 19.
  • 32
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 190313.
  • 33
    Antikainen RL, Moltchanov VA, Chukwuma C Sr et al. Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project. Eur J Cardiovasc Prev Rehabil 2006; 13: 1329.
  • 34
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290: 199206.
  • 35
    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 2010; 303: 204350.
  • 36
    Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, Jansson JH. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med 2007; 262: 3607.
  • 37
    Lewington S, Whitlock G, Clarke R et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370: 182939.
  • 38
    Carroll MD, Lacher DA, Sorlie PD et al. Trends in serum lipids and lipoproteins of adults, 1960–2002. JAMA 2005; 294: 177381.
  • 39
    Rosengren A. Declining cardiovascular mortality and increasing obesity: a paradox. CMAJ 2009; 181: 1278.
  • 40
    Hobbs MS, Knuiman MW, Briffa T, Ngo H, Jamrozik K. Plasma cholesterol levels continue to decline despite the rising prevalence of obesity: population trends in Perth, Western Australia, 1980–1999. Eur J Cardiovasc Prev Rehabil 2008; 15: 31924.
  • 41
    Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med 2009; 361: 225260.
  • 42
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010; 303: 23541.
  • 43
    Wareham NJ, Forouhi NG. Is there really an epidemic of diabetes? [comment]. Diabetologia 2005; 48: 14545.
  • 44
    Berger B, Stenström G, Sundkvist G. Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry. Diabetes Care 1999; 22: 7738.
  • 45
    Jansson SP, Andersson DK, Svardsudd K. Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up. Diabetologia 2007; 50: 70310.
  • 46
    Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996–2005. J Epidemiol Community Health 2009; 63: 3326.
  • 47
    Eliasson M, Talback M, Rosen M. Improved survival in both men and women with diabetes between 1980 and 2004 – a cohort study in Sweden. Cardiovasc Diabetol 2008; 7: 32.
  • 48
    Stovring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 2003; 362: 5378.
  • 49
    Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993; 88: 197398.
  • 50
    Jansson JH, Boman K, Messner T. Trends in blood pressure, lipids, lipoproteins and glucose metabolism in the Northern Sweden MONICA project 1986–99. Scand J Public Health Suppl 2003; 61: 4350.